Overview

Omega-3 for Peri- and Postmenopausal Depression

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if an eight-week intervention with omega-3 fatty acids significantly reduces depressive symptoms in symptomatic peri- and postmenopausal women. We hypothesize that an eight-week trial with omega-3 fatty acids promotes significant improvement in depression symptoms in peri- and postmenopausal women.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
GlaxoSmithKline